FindTrial
Sign In

Lower limb trength after femoral nerve block by ropivacaine in men and women

The clinical study of the gender differences in the functional inhibition of quadriceps sinus muscle during femoral nerve block

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014562
Enrollment
Unknown
Registered
2018-01-21
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

motor block

Interventions

men/women:inguinal femoral nerve block

Sponsors

The First Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ASA I-II, aged 18-65 years, height 160-170cm, weight 55-65kg, and BMI 18.5 to 24, scheduled to have the great saphenous vein stripping operation.

Exclusion criteria

Exclusion criteria: Knee extension disorder, those allergic to amide local anaesthetics or with skin inflamed at the puncture site,those with peripheral arteriosclerosis.

Design outcomes

Primary

MeasureTime frame
EC50 of ropivacaine of the quadriceps muscle blockage;—

Countries

China

Contacts

Public ContactGan Shuyuan

The First Affiliated Hospital, College of Medicine, Zhejiang University

ganshuyuan@163.com+86 13600527369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026